期刊文献+

奥氮平用于维持性精神分裂症治疗的临床效果分析 被引量:3

Analysis of the Clinical Effect of Olanzapine for Maintenance Treatment of Schizophrenia
下载PDF
导出
摘要 目的研究分析奥氮平用于维持性精神分裂症治疗的临床效果。方法选取在该院治疗的维持性精神分裂症患者60例(2013年4月—2015年6月)。将其动态随机化分为研究组和对照组各30例。对照组患者给予氯氮平治疗,研究组患者给予奥氮平进行治疗,对比两组患者的临床疗效与不良反应发生情况。结果研究组患者的临床总有效率(96.67%)与对照组比较差异有统计学意义(P<0.05);研究组患者不良反应发生率(13.33%)与对照组患者相对比差异有统计学意义(P<0.05)。结论采用奥氮平对维持性精神分裂症患者进行治疗的效果显著,能降低患者不良反应的发生,在临床上可以广泛应用。 Objective To study the clinical effect of olanzapine for maintenance treatment of schizophrenia. Methods60 patients with maintenance schizophrenia treated in our hospital were selected(April 2013—June 2015).The dynamic randomization was divided into study group and control group,each of 30 cases.In the control group were treated with clozapine treatment,patients in study group were given olanzapine treatment,the clinical efficacy and adverse reaction of patients in the two groups were compared. Results Patients in the study group,the clinical total efficiency(96.67%)and compared to the control group,there is significant difference(P<0.05);study group of patients with adverse reactions occurred rate(13.33%) and the control group of patients compared with significant difference(P<0.05). Conclusion The use of olanzapine to maintain the spirit of schizophrenia patients with obvious treatment effect,can reduce the occurrence of adverse reactions in patients,in clinical on can be widely used.
作者 王敬巍
出处 《系统医学》 2016年第8期13-14,共2页 Systems Medicine
关键词 奥氮平 维持性精神分裂症 临床效果 Olanzapine Schizophrenia maintenance spirit Clinical effect
  • 相关文献

参考文献9

二级参考文献74

  • 1耿玉辰,耿姝霞.奥氮平与齐拉西酮治疗青少年精神分裂症疗效的对比研究[J].中国医药指南,2008,6(18):60-61. 被引量:7
  • 2William Nseir,Fares Nassar,Nimer Assy.Soft drinks consumption and nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2010,16(21):2579-2588. 被引量:20
  • 3李娜,许秀峰.奥氮平的药理学和临床应用[J].云南医药,2004,25(6):520-524. 被引量:8
  • 4吴文源.症状自评量表[A].张明园主编.精神科量表评定手册[M] 第2版[C].长沙:湖南科学技术出版社,1998.16-27.
  • 5Henderson D C, Xiaoduo Fan, Paul M, et ah Aripiprazole added to o- verweight and obese olanzapine - treated schizophrenia patients [ J ]. JClin Psyehopharmaeol, 2009,29 ( 2 ) : 165-169.
  • 6David C, Henderson M, Xiaoduo Fan, et al. AJripiprazole added to over - weight and obse olanzapine - treated schizophrenia patients [ J ]. J Clin Psychopharmacology ,2009,29 ( 2 ) : 165-169.
  • 7陆静尔,任跃忠.胰岛素样生长因子与胰岛素抵抗研究进展[J].2008,30(9):1025-1026.
  • 8Moses A C. Insulin resistance and type2 diabetes mellitus:Is there a therapeutic role for IGF I[J]. Endocr Dev,2005,9(2) :121-134.
  • 9Perez - Iglesias R, Mata I, Pelayo - Teran J M, et al. Glucose and lipid disturbances after 1 year of antipsychotie treatment in a drug - naiive population [ J ]. Schizophr Res,2008,102 ( 1-3 ) : 329-336.
  • 10Sjogren K, Wallenius K, Liu J L, et al. Liver - derived IGF - I is of importance for normal carbohydrate and: lipid metabolism[ J]. Diabe- tes,2001,50(7) :1539-1545.

共引文献139

同被引文献28

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部